The Royal Devon and Exeter Hospital, is a large teaching hospital situated in Exeter, Devon, England. The hospital has two sites, situated in Wonford and Heavitree, Exeter, and is part of the Royal Devon and Exeter NHS Foundation Trust.

During the past decade, Royal Devon and Exeter Hospital conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 42 clinical trials were completed, i.e. on average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 32 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Devon and Exeter Hospital" #1 sponsor was "Royal Devon and Exeter NHS Foundation Trust" with 22 trials, followed by "University College, London" with 13 trials sponsored, "Institute of Cancer Research, United Kingdom" with 11 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored and "Medical Research Council" with 10 trials sponsored. Other sponsors include 143 different institutions and companies that sponsored additional 104 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Devon and Exeter Hospital" #1 collaborator was "Cancer Research UK" with 11 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator, "Royal Devon and Exeter NHS Foundation Trust" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator and "Syneos Health" with 5 trials as a collaborator. Other collaborators include 152 different institutions and companies that were collaborators in the rest 137 trials.

According to Clinical.Site data, the most researched conditions in "Royal Devon and Exeter Hospital" are "Breast Cancer" (16 trials), "Cystic Fibrosis" (11 trials), "Prostate Cancer" (10 trials), "Bladder Cancer" (6 trials) and "Idiopathic Pulmonary Fibrosis" (6 trials). Many other conditions were trialed in "Royal Devon and Exeter Hospital" in a lesser frequency.

Most popular intervention types in "Royal Devon and Exeter Hospital" are "Drug" (128 trials), "Procedure" (37 trials), "Other" (28 trials), "Biological" (25 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "radiation therapy" (10 trials), "IVA" (8 trials), "adjuvant therapy" (8 trials) and "cyclophosphamide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Royal Devon and Exeter Hospital" are 177 trials for "All" genders, 22 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 62 active trials in "Royal Devon and Exeter Hospital". 2 are not yet recruiting, 33 are recruiting, 26 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 110 completed trials in Royal Devon and Exeter Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Devon and Exeter Hospital, 10 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 36 trials that are defined as “Not Applicable".

Royal Devon and Exeter Hospital has several departments that took part in Clinical trials: "Royal Devon & Exeter Hospital; Oncology Centre" - 7 trials, "Emergency Department" - 2 trials, "Royal Devon and Exeter Hospital, Department of Gastroenterology" - 2 trials